Search Results
ANTIPLATELETS AND NOACS - USE IN DIABETES
Novel Anticoagulants and Antiplatelet Agents- Dr. Stuart Christenson, 2/21/13
The New Anticoagulants in Cardiovascular Disease: Atrial Fibrillation and Beyond
Direct-Acting Oral Anticoagulants (DOACs) | MOA , Indications, Adverse Reactions, Contraindications
Optimizing Antiplatelet Therapy in Diabetes Mellitus | Dominick J. Angiolillo
Pharmacology - ANTICOAGULANTS & ANTIPLATELET DRUGS (MADE EASY)
Newer Anticoagulants in Atrial Fibrillation: Should I Incorporate Them Into Clinical Practice?
NOAC vs Warfarin, Current Status of Venous Anticoagulation (Baltazar MD; Petkova MD) March 24, 2021
Stroke Prevention in Atrial Fibrillation
Warfarin versus the NOACs for the treatment of atrial fibrillation
Novel oral anticoagulants #NOACs about #Rivaroxaban #dabigatran #apixaban
JoEllyn Moore, MD; Nedaa Skeik, MD; Mario Gössl, MD, PhD - Anticoagulation and Antiplatelet Agents
